Boehringer Ingelheim obtains ad-interim injunctions on 4 Indian pharma cos ...Middle East

The firms had launched generic versions of Boehringer's patent-protected drug Linagliptin, which is marketed under the brand name Trajenta

Hence then, the article about boehringer ingelheim obtains ad interim injunctions on 4 indian pharma cos was published today ( Tuesday 07/06/2022 - 05:12 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Boehringer Ingelheim obtains ad-interim injunctions on 4 Indian pharma cos )

Also on site :

• After months of restraint, treasury secretary joins attacks on Fed chief
• Pets are family. But can you claim them as dependents on your tax return?
• Gold and Silver Prices Hit New Record Highs Globally